Mr. Speaker, the purpose of motions and being here at this time on a Friday is the opportunity for us to discuss and move forward not legislation, but concepts and ideas that need to be turned into either government legislation or concepts. I find it interesting that the member for Vancouver would actually use this time to accuse the government of not taking action when the individual who actually moved this motion is a member of the government and is on this side of the House.
So much for trying to work together, because I do not think that this issue crosses any type of partisan lines whatsoever. It is an issue that all Canadians are interested in, particularly the more than two million Canadians who are impacted by anaphylaxis.
I am pleased to be able to take this opportunity and speak today about Motion No. 230, tabled by our colleague, the member for Niagara West—Glanbrook. This motion states that anaphylaxis is a serious concern for an increasing number of Canadians, and calls for the government to take appropriate measures to ensure these Canadians are able to maintain a high quality of life.
When allergens come into contact with the skin, are inhaled into the lungs, or are swallowed or injected, a person can develop allergic symptoms almost immediately. These symptoms can develop quickly. Within minutes, a mild allergic reaction can potentially progress to a severe one. Anaphylaxis is the most serious type of allergic reaction.
Mild allergic symptoms may include itchy skin or watery eyes. However, the most dangerous of symptoms can include trouble breathing, a drop in blood pressure causing dizziness, light-headedness, feeling faint or weak, or losing consciousness. In the most severe cases, these symptoms can be life-threatening.
There are a number of research studies which suggest that the number of people who live with allergies is increasing, and that many of those living with the most severe allergies are our youth and our children. However, the impact of allergies, especially anaphylaxis, on Canadian individuals and on Canadian society as a whole, remains largely unknown.
The Government of Canada is committed to protecting the health and safety of Canadians living with allergies. There has been significant scientific progress made in this area, but there is still a great deal more to learn about allergens, anaphylaxis, and allergies. This is why the government has invested in a broad range of research studies that are not only helping us to better understand the prevalence and impacts of food allergies in Canada, but are also serving to inform policies and regulations which will help to minimize health risks caused by severe allergic reactions.
The Government of Canada is supporting research in the area of anaphylaxis and food allergies through the Canadian Institutes of Health Research. Since its inception in 2000, CIHR has funded a number of projects to better understand the fundamental causes of different allergies, such as food allergies, which in turn can cause anaphylaxis. These investments are also contributing to developing new treatments, therapeutics, and guidelines for better prevention and treatment.
For example, the CIHR is funding the allergy, genes, and environment network centre of excellence, which brings together more than 170 researchers and 200 partners from the industry, the public service, and academia. The network aims at catalyzing and supporting the work necessary to reduce the burden of allergy, asthma, and anaphylaxis. We are investing more than $60 million in this work between our coming to government in 2006 and the year 2019.
Health Canada is also supporting a variety of research projects in the field of food allergies. These projects are of critical importance to help fill the knowledge gaps and to support policy development.
Between the years 2007 and 2009, a study surveying Canadians to assess the prevalence of common food allergies and attitudes towards food labelling and risk was undertaken and was the first nationwide Canadian examination of the prevalence of common food allergies. It was carried out under the leadership of some of Canada's top academics and supported by the allergy, genes, and environment network, funded through the federal networks of centres of excellence program, which I just mentioned.
The allergy, genes, and environment network, also called AllerGen NCE Inc., worked in partnership on this study with Health Canada, McMaster Institute of Environment and Health, McGill University Health Centre, Montreal Children's Hospital, Anaphylaxis Canada and the Allergy/Asthma Information Association.
This important research provided a better estimate of the prevalence of people with common food allergies in Canada, which as I mentioned earlier is approximately 2.5 million Canadians. The study also found that over 15 million Canadians, or 50.6%, reported being directly or indirectly affected by food allergies. Over six million Canadians reported having someone in their household who is allergic to food.
Further, this study has provided a better understanding of the attitudes and behaviours of those living with these medical conditions, including the attitudes of the general public towards food allergies and the effectiveness of food labelling that alerts consumers to the presence of allergens in products. The findings of this study have been key to informing the government's position on food allergen labelling and the development of the new food allergen labelling regulations which were brought into force last year. The information gathered from the study is of great value to the government and stakeholders in the development of policy, health, and educational resources. It is needed to support prevention, and to help with the diagnosis and management of food allergies in Canada.
As a follow-up to this study, the Government of Canada supported a survey of the prevalence of food allergies in all Canadian environments. This comprehensive study, which took place between 2009 and 2011, included the development of a full picture of the health, social, and economic impacts of food allergies in our country.
It examined the prevalence of food allergies in vulnerable populations across Canada, including among people of lower socio-economic status, new Canadians, and first nations and Inuit populations. The study also explored the role of contributing factors, such as environmental influences as they related to the potential cause of food allergies.
Building upon the findings of these two studies, the Cross-Canada Anaphylaxis Registry, or C-CARE, is a study currently under way. It will develop a registry of anaphylaxis cases throughout our country. Preliminary work, as part of this registry, revealed that among young children visiting emergency departments, the rate of anaphylaxis diagnosed is comparable to that found in studies conducted in the U.S. and that food is the main trigger. The objective of the study is to contribute to reducing the incidence of anaphylaxis which will help minimize the burdens of anaphylaxis, including associated health care costs.
I would like to commend the member for Niagara West—Glanbrook for his efforts to bring this important issue forward. I recommend that my colleagues from all parties support Motion No. 230.
Our government acknowledges that anaphylaxis is a serious health concern to Canadians living with allergies. The government has put in place a range of measures necessary to help Canadians who live with allergies maintain a high quality of life.
Motion No. 230 reflects the concerns of Canadians affected by life-threatening allergies. Supporting this motion reaffirms our commitment to protecting the health and safety of Canadians with serious allergies. In conclusion, whether it be the community of Niagara West—Glanbrook, the city of St. Catharines, or anywhere in our country, we have those who are impacted by this issue. We need to take action in terms of moving this forward.
I want to commend my colleague from Niagara West—Glanbrook who has been persistent with this motion. He had it up in the last Parliament. He had it up again here today. We are seeing this motion move forward. Moving forward means concrete action, and that is what the member's intention has always been.
I would also like to thank a good friend of mine, a fellow by the name of Chris George whose son is threatened by anaphylaxis. In fact he pulled me into this. At first I was not sure how far-reaching or how significant this issue was in our country. He convinced me by showing the impact it has across the country and in each one of our communities.
I say to him, his son, and his family, this is our step forward in terms of making sure that regardless of how difficult it is, we are taking action. We will continue to act on behalf of those who are impacted by anaphylaxis.